ArticleClinical kidney journal2025
Uraemic burden index: a novel predictor of pre-emptive kidney transplant outcome.
Article in Clinical kidney journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Timing of pre-emptive kidney transplantation (PKT) and the role of estimated glomerular filtration rate (eGFR) change in outcome prediction remains a subject of debate. This study aimed to assess potential factors, with special attention to uraemic burden, which may be associated with 5-year outcomes. In our retrospective observational cohort study, first PKT adults registered in the CRISTAL database between 2013 and 2019 were analysed to elucidate the role of eGFR and other associating factors with death and graft loss. Recipient-, donor- and transplantation-related features were analysed by using multivariable logistic regression analysis. A conditional inference tree was applied for risk stratification. A total of 2327 first PKT [52.8 years (interquartile range 43-64), 38% female) were included. The mean percentage of PKT over time was 14%. Primary kidney disease (congenital anomalies, glomerulonephritis and other causes versus autosomal dominant polycystic kidney disease), donor age and number of DR mismatches associated with combined 5-year outcomes [odds ratio 2.64 (95% confidence interval 1.42-4.93); 1.94 (1.1-4.93); 1.76 (1.06-2.92); 1.03 (1.02-1.05); 1.67 (1.1-2.53);
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.